Clinical Trials Logo

Human Papilloma Virus (HPV) clinical trials

View clinical trials related to Human Papilloma Virus (HPV).

Filter by:
  • None
  • Page 1

NCT ID: NCT03987490 Completed - Clinical trials for Human Papilloma Virus (HPV)

Usability of HPV Vaccine Reminders

Start date: December 1, 2015
Phase: N/A
Study type: Interventional

This study will assess the usefulness of parent-targeted strategies in improving care seeking among parents of 11-12 year old adolescents. Specifically, the study team will focus on reminders (postcard or text message) and motivational interviewing to improve adolescent vaccination.

NCT ID: NCT00715234 Completed - Varicella Clinical Trials

Evaluation of Vaccination Reminder/Recall Systems for Adolescent Patients

Start date: October 2007
Phase: N/A
Study type: Interventional

A study team with extensive experience in immunization delivery research will evaluate the effectiveness of vaccination reminder/recall systems for adolescent patients in five types of clinical settings including: urban pediatric, urban family medicine and rural family medicine practices, public pediatric clinics, and school-based health centers. Randomized controlled trials of reminder/recall for adolescents will be conducted at each type of site, with randomization at the level of the patient.

NCT ID: NCT00709891 Completed - Clinical trials for Human Papilloma Virus (HPV)

Evaluation of the Cobas® 4800 HPV Test for the Detection of High-grade Cervical Disease

Start date: May 2008
Phase: N/A
Study type: Interventional

This study provided data on the performance of the Cobas® 4800 HPV Test for identifying histologically confirmed high-grade cervical disease. The baseline, cross-sectional phase was conducted in approximately 45,000 women undergoing routine cervical cancer screening, of whom approximately 7,400 were selected to undergo colposcopy and biopsy/endocervical curettage (ECC) at baseline. These subjects included women with cytology that is 'not normal' and a selection of those with 'normal' cytology who entered a follow-up phase and underwent cytological evaluation annually for 3 years. In this follow-up phase, colposcopy and biopsy/ECC were performed only in women with cervical cytology considered 'not normal' at any of the annual follow-up visits.